# Cero Therapeutics Holdings, Inc.: Form 8-K, filed Jun 11, 2025

- Company: [Cero Therapeutics Holdings, Inc.](/companies/cero.md) (CIK 1870404)
- Form: 8-K
- Filed: 2025-06-11
- Accepted by EDGAR: Jun 11, 2025, 09:20 ET
- Period: 2025-06-11
- Accession: 0001213900-25-053292
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1870404/000121390025053292/ea0245328-8k_cero.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1870404/000121390025053292/

## Items reported

- Item 5.03: Amendment to articles or bylaws
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1870404/000121390025053292/ea0245328-8k_cero.htm

Filed Jun 11, 2025.
Source: SEC EDGAR, the filing index for accession 0001213900-25-053292. Last ingested by Listed: Nov 14, 2026, 19:08 ET. No prices; not investment advice.